Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients

This study has been completed.

Study NCT00002052. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields
Brief Title ^†	Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients
Official Title ^†	Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients
Brief Summary	To compare the effectiveness of standard treatment with parenteral ampicillin and oral amoxicillin compared to initial daily therapy with ceftriaxone followed by 3 times weekly suppressive treatment for salmonella infections in AIDS patients.
Detailed Description
Study Phase
Study Type ^†	Interventional
Study Design ^†	Treatment, Dose Comparison
Primary Outcome Measure ^†
Secondary Outcome Measure ^†
Condition ^†	HIV Infections Salmonella Infections
Intervention ^†	Drug: Ceftriaxone sodium Drug: Ampicillin sodium Drug: Amoxicillin trihydrate
MEDLINE PMIDs
Links

Recruitment Information Fields
Recruitment Status ^†	Completed
Enrollment ^†
Start Date ^†
Completion Date
Eligibility Criteria ^†	Exclusion Criteria Co-existing Condition: Patients with the following are excluded: Type I hypersensitivity to beta-lactam antibiotics. Not expected to survive 12 weeks. In a coma or with other central nervous system (CNS) impairment. Patients with the following are excluded: Type I hypersensitivity to beta-lactam antibiotics. Not expected to survive 12 weeks. In a coma or with other central nervous system (CNS) impairment. Prior Medication: Excluded within 48 hours of study entry: Treatment with an antibiotic active in vitro against Salmonella. HIV infection, AIDS, or AIDS related complex (ARC). Salmonella bacteremia or positive stool culture in patient with 3 or more stools per day.
Gender	Both
Ages	18 Years and older
Accepts Healthy Volunteers	No
Contacts ^††
Location Countries ^†	United States

Administrative Information Fields
NCT ID ^†	NCT00002052
Organization ID	019A
Secondary IDs ^††
Study Sponsor ^†	University of Southern California
Collaborators ^††
Investigators ^†
Information Provided By	NIH AIDS Clinical Trials Information Service
Verification Date	August 1989
First Received Date ^†	November 2, 1999
Last Updated Date	June 23, 2005

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.